Nanjing Kaiji Bio-engineering

Nanjing KeyGEN Bio-tech is a prominent Chinese biotechnology company that specializes in the development, production, and sale of biological reagents and the provision of comprehensive technical services. Founded in 2000 and headquartered in Nanjing, the company has established itself as a leader in the field of cell apoptosis detection and life science research tools. Their product catalog includes over 3,000 items such as assay kits, antibodies, and recombinant proteins, while their service arm provides molecular biology, proteomics, and animal model support. KeyGEN Bio-tech is listed on the National Equities Exchange and Quotations (NEEQ) and serves a global clientele of academic institutions and pharmaceutical enterprises. The company's integrated platform facilitates efficient R&D workflows for drug discovery and basic biological research.